يعرض 1 - 10 نتائج من 21 نتيجة بحث عن '"Multicenter collaboration"', وقت الاستعلام: 1.18s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المؤلفون: Christensen, Jakob

    المصدر: Christensen , J & EpiNet Study Group 2017 , ' EpiNet as a way of involving more physicians and patients in epilepsy research: Validation study and accreditation process ' , Epilepsia open , vol. 2 , no. 1 , pp. 20-31 . https://doi.org/10.1002/epi4.12033Test

  6. 6
    دورية أكاديمية

    المؤلفون: C.K. Li, Ч.К. Ли

    المصدر: Russian Journal of Pediatric Hematology and Oncology; Том 3, № 3 (2016); 37-46 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 3, № 3 (2016); 37-46 ; 2413-5496 ; 2311-1267 ; 10.17650/2311-1267-2016-3-3

    وصف الملف: application/pdf

    العلاقة: https://journal.nodgo.org/jour/article/view/245/241Test; https://journal.nodgo.org/jour/article/view/245/242Test; Yoshida H., Imamura T., Saito A.M. et al., for the Japan Association of Childhood Leukemia Study. Protracted Administration of L-Asparaginase in Maintenance Phase Is the Risk Factor for Hyperglycemia in Older Patients with Pediatric Acute Lymphoblastic Leukemia. PLoS One 2015;10(8):e0136428.; Manabe A., Kawasaki H., Shimada H. et al. Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph(+) ALL04. Cancer Med 2015;4:682–9.; Hyakuna N., Shimomura Y., Watanabe A. et al. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group. J Pediatr Hematol Oncol 2014;36:22–9.; Guo Y., Liu T.F., Ruan M. et al. Efficacy and safety of imatinib for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in children. Zhongguo Dang Dai Er Ke Za Zhi (The Chinese Jounral of Contemporary Pediarics) 2015;17:819–24.; Liu X., Zou Y., Wang H. et al. Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol. Zhonghua Er Ke Za Zhi (The Chinese Journal of Pediatrics) 2014;52(6):449–54.; Karachunskiy A., Herold R., von Stackelberg A. et al. Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia. Leukemia 2008;22(6):1144–53.; Karachunskiy A., Roumiantseva J., Lagoiko S. et al. Efficacy and toxicity of dexamethasone vs methylprednisolone-longterm results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002. Leukemia 2015;29(9):1955–8.; Rumiantseva Iu.V., Karachunskiĭ A.I., Aleĭnikova O.V. et al. Efficiency of the ALLMB-2002 protocol in children with acute lymphoblastic leukemia. Ter Arkh 2010;82(7):11–9.; Liang D.C., Yang C.P., Liu H.C. et al. NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia. Pharmacogenomics J. 2015 Oct 27. Doi:10.038/tpj.2015.75.; Yen H.J., Chang W.H., Liu H.C. et al. Outcomes Following Discontinuation of E. coli L-Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia. Pediatr Blood Cancer 2016;63:665–70.; Seksarn P., Wiangnon S., Veerakul G. et al. Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the Thai National Protocols. Asian Pac J Cancer Prev 2015;16(11):4609–14.; Fadoo Z., Nisat I., Yousuf F. e al. Clinical features and induction outcome of childhood acute lymphoblastic leukemia in a lower/ middle income population: A multiinstitutional report from Pakistan. Pediatr Blood Cancer 2015;62:1700–8.; Al-Sudairy R., Al-Nasser A., Alsutan A. et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia in Saudi Arabia: a multiinstitutional retrospective national collaborative study. Pediatr Blood Cancer 2014;61:74–80.; Al-Mulla N.A., Chandra P., Khattab M. et al. Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA). Pediatr Blood Cancer 2014;61(8):1403–10.; Yeoh A.E., Ariffin H., Chai E.L. et al. Minimal residual disease-guided treatment deintensification for children with acute lymphoblastic leukemia: results from the Malaysia-Singapore acute lymphoblastic leukemia 2003 study. J Clin Oncol 2012;30(19):2384–92.; Stary J., Zimmermann M., Campbell M. et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized international trial ALL ICBFM 2002. J Clin Oncol 2014;32:174–84.; https://journal.nodgo.org/jour/article/view/245Test

  7. 7
  8. 8
    دورية أكاديمية
  9. 9
    مورد إلكتروني
  10. 10
    مورد إلكتروني